BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed GOSS catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:195cceccd83da22a1ae8@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:GOSS P3 readout (est.): Open-label Extension Study of Seralutinib i
 n Adult Subjects With PAH (PROSERA-EXT)
DESCRIPTION:Open-label Extension Study of Seralutinib in Adult Subjects Wit
 h PAH (PROSERA-EXT)\nNCT06274801 | PHASE3 | RECRUITING | sponsor: Gossamer
  Bio USA\, Inc.\nPrimary completion date (ESTIMATED)\; top-line results us
 ually follow later.\nDate precision: month (shown on the first day)\nTicke
 r GOSS (confidence 0.6)\nSource: https://clinicaltrials.gov/study/NCT06274
 801\nScheduling/reference data from public records\; dates can move. Not i
 nvestment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06274801
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
